首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Clinical Pharmacokinetics

Clinical Pharmacokinetics杂志,由Springer International Publishing出版,于1976年创刊,Monthly,出版语言English,ISSN:0312-5963,E-ISSN:1179-1926。

投稿咨询
Clinical Pharmacokinetics
Clinical Pharmacokinetics
Clinical Pharmacokinetics
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
2区
影响因子
4
CiteScore
7.6
期刊收录
SCI、SCIE

Clinical Pharmacokinetics(中文译名:《临床药代动力学》),ISSN:0312-5963,EISSN:1179-1926,是Springer International Publishing出版的国际性学术期刊,创刊于1976年,以Monthly形式稳定发行,2026年总发文量约130篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4,2025年期刊CiteScore为7.6,2025年期刊自引率约5%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Clinical Pharmacokinetics长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USANetherlands、GERMANY (FED REP GER)、France、England、Switzerland、Australia等为核心发文国家与地区;ERASMUS UNIVERSITY ROTTERDAMRADBOUD UNIVERSITY NIJMEGEN、UNIVERSITY OF LONDON、ABBVIE、INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、LEIDEN UNIVERSITY、UNIVERSITY OF QUEENSLAND等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 109 / 356

69.5

学科:PHARMACOLOGY & PHARMACY SCIE Q2 92 / 356

74.3

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 83 / 352

76.6

学科:PHARMACOLOGY & PHARMACY SCIE Q1 84 / 353

76.35


中国学者近期发文

1
Population Pharmacokinetics for Pediatric Extrapolation of GenSci006: A 3.75-mg Triptorelin Acetate Microsphere Formulation for Central Precocious Pubert

Author:Wang, Kun; Sun, Zhongyi; Xu, Fengyan; Liu, Lu; Luo, Tianhong; Gao, Weiwei; Zhao, Tangping; Ma, Guangli; Zhu, Xiaoyan

Journal: CLINICAL PHARMACOKINETICS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40262-026-01634-4

2
Pharmacokinetics, Pharmacodynamics and Safety of Fultagliptin Benzoate Tablets, a DPP-4 Inhibitor, in Patients With Varying Degrees of Renal Insufficiency and Matched Healthy Volunteers: A Phase I Clinical Tria

Author:Chen, Yue; Hu, Chao; Cao, Xiaotao; Men, Yuchun; Wang, Ying; Zhang, Ruijie; Guan, Hongyu; Shi, Lihong; Liu, Fang; Miao, Jia

Journal: CLINICAL PHARMACOKINETICS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40262-026-01622-8

3
Population Pharmacokinetic and Pharmacodynamic Modeling to Support Molar Dose Ratio Determination of Long-Acting Insulin Analog

Author:Tang, Dan; Gao, Xuehu; Zhu, Min; Shu, Chang; Dong, Yanli; Yu, Xiaoling; Chen, Hong; Li, Xiaojuan; Zhang, Xiaoli; Cai, Daren; Feng, Sheng

Journal: CLINICAL PHARMACOKINETICS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40262-025-01598-x

4
Clinical Pharmacokinetics of Inhaled Drugs for Pulmonary Hypertensio

Author:Lin, Yu; Su, Yuanqi; Cheng, Zhongjie; Zhu, Bing; Pei, Qi

Journal: CLINICAL PHARMACOKINETICS. 2025; Vol. 64, Issue 7, pp. 973-986. DOI: 10.1007/s40262-025-01525-0

5
Effect of Obesity on Pharmacokinetics of Lidocaine and its Active Metabolites in Chinese Patients Undergoing Laparoscopic Bariatric Surgery: A Prospective Clinical Stud

Author:Zhang, Mengyu; Jin, Ying; Yuan, Xueying; He, Chaoqun; Han, Mei; Tu, Faping; Wang, Zhenlei

Journal: CLINICAL PHARMACOKINETICS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40262-025-01510-7

6
Determining the Optimal Dosing of Methyldopa in Pregnancy-Induced Hypertension Using PBPK-PD Modelin

Author:Liu, Xinyang; Wang, Wei; Zhu, Jinying; Chen, Jingsi; Wang, Xiaoyi; Chen, Dunjin; Ouyang, Defang

Journal: CLINICAL PHARMACOKINETICS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40262-025-01523-2

7
Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthm

Author:Jin, Yuwen; Guiastrennec, Benjamin; Stuke, Miriam; Yao, Yuhui; Zhang, Yajuan; Barker, Peter; Jison, Maria; Penland, Robert C.; Ding, Junjie; Lukka, Pradeep B

Journal: CLINICAL PHARMACOKINETICS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40262-025-01538-9

8
Prediction of Interspecies Translation for Targeting Delivery Coefficients of GalNAc-siRNA Silencing Apolipoprotein C-III Using a Mechanistic Minimal Physiologically Based Pharmacokinetic/Pharmacodynamic Mode

Author:Tian, Zhiteng; Luo, Hui; Chu, Yantao; Liu, Yanhong; Gao, Shan; Song, Ling; Yang, Zhenzhen; Liu, Dongyang

Journal: CLINICAL PHARMACOKINETICS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40262-025-01513-4

9
Maternal-Fetal Physiologically Based Population Pharmacokinetics Model Development of Lopinavir/Ritonavir in HIV/HBV Co-infected Pregnant Women to Quantitatively Describe the Gestational PK Characteristics and Predict the Potential Disease-Drug-Drug Interaction (DDDI

Author:Song, Ling; Guo, Xuan; Yang, Wei; Song, Jie; Liu, Dongyang

Journal: CLINICAL PHARMACOKINETICS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40262-025-01493-5

10
Pharmacokinetics and Pharmacodynamics of Prusogliptin (DBPR108), a Once-Daily Dipeptidyl Peptidase-4 Inhibitor, in Patients with Type 2 Diabete

Author:Liu, Wenfang; Yang, Kexu; Lin, Yang; Lu, Chunyan; Liu, Jingyi; Zhou, Huan; Wang, Juan; Zhang, Tianhao; Yao, Lingli; Qi, Huanhuan; Zhang, Xiaofang; Jia, Rui; Li, Xiaoli; Jing, Shan

Journal: CLINICAL PHARMACOKINETICS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40262-025-01501-8


在线咨询

Clinical Pharmacokinetics

国际简称:CLIN PHARMACOKINET参考译名:临床药代动力学

年发文量:130 CiteScore:7.6 是否预警:否 Gold OA文章占比:58.87% 研究类文章占比:76.15%

杂志社联系方式:ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311

Clinical Pharmacokinetics